These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2630252)

  • 1. Bacteriolytic combination effect of cefminox and piperacillin evaluated by turbidimetry.
    Goi H; Inouye S; Kitasato I
    Drugs Exp Clin Res; 1989; 15(9):397-407. PubMed ID: 2630252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of cefminox, a new bactericidal cephamycin.
    Watanabe S; Omoto S
    Drugs Exp Clin Res; 1990; 16(9):461-7. PubMed ID: 2100248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.
    Goi H; Watanabe T; Miyauchi K; Kazuno Y; Inouye S
    Drugs Exp Clin Res; 1985; 11(11):771-80. PubMed ID: 3915467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro and in vivo activity of cefminox (MT-141), cefotaxime and cefoperazone against gram-negative bacteria.
    Watanabe T; Kazuno Y; Hirano F; Inouye S; Nishino T
    Drugs Exp Clin Res; 1985; 11(11):781-6. PubMed ID: 3841789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics.
    Debbia EA; Schito GC; Stefani S; Nicoletti G
    Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    Obi CL; Makandiramba B; Robertson V; Tswana SA; Moyo SR; Nziramasanga P
    East Afr Med J; 1998 Mar; 75(3):162-5. PubMed ID: 9640815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the combination of erythromycin with new beta-lactam antibiotics against gram-negative aerobic respiratory pathogens.
    Nakatomi M; Neu HC
    Chemioterapia; 1986 Dec; 5(6):379-84. PubMed ID: 3802298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro bactericidal effect of cefotetan-aminoside combinations].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):361-5. PubMed ID: 3043329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefminox: correlation between in-vitro susceptibility and pharmacokinetics and serum bactericidal activity in healthy volunteers.
    Aguilar L; Esteban C; Frias J; Pérez-Balcabao I; Carcas AJ; Dal-Ré R
    J Antimicrob Chemother; 1994 Jan; 33(1):91-101. PubMed ID: 8157579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inoculum size on bacteriolytic activity of cefminox and four other beta-lactam antibiotics against Escherichia coli.
    Soriano F; Edwards R; Greenwood D
    Antimicrob Agents Chemother; 1992 Jan; 36(1):223-6. PubMed ID: 1590693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of cefminox in human urine].
    Goi H; Watanabe T; Hara T; Ishii T; Kazuno Y; Inouye S
    Jpn J Antibiot; 1988 Jan; 41(1):25-36. PubMed ID: 3367512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cefminox on bacterial flora in human adult feces].
    Motohiro T; Aramaki M; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Nishiyama T; Kuda N
    Jpn J Antibiot; 1986 Apr; 39(4):909-57. PubMed ID: 3761549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative turbidimetric assay of enzymatic gram-negative bacteria lysis.
    Levashov PA; Sedov SA; Shipovskov S; Belogurova NG; Levashov AV
    Anal Chem; 2010 Mar; 82(5):2161-3. PubMed ID: 20136093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.